Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 61-66, January 2008

Preparation and first evaluation of [18F]FE@SUPPY: a new PET tracer for the adenosine A3 receptor

  • Wolfgang Wadsak

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Inorganic Chemistry, University of Vienna, A-1090 Vienna, Austria
  • ,
  • Leonhard-Key Mien

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, A-1090 Vienna, Austria
    • Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Karem Shanab

      Affiliations

    • Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, A-1090 Vienna, Austria
  • ,
  • Dagmar E. Ettlinger

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Daniela Haeusler

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, A-1090 Vienna, Austria
  • ,
  • Karoline Sindelar

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Rupert R. Lanzenberger

      Affiliations

    • Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Helmut Spreitzer

      Affiliations

    • Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, A-1090 Vienna, Austria
  • ,
  • Helmut Viernstein

      Affiliations

    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, A-1090 Vienna, Austria
  • ,
  • Bernhard K. Keppler

      Affiliations

    • Department of Inorganic Chemistry, University of Vienna, A-1090 Vienna, Austria
  • ,
  • Robert Dudczak

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Kurt Kletter

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Markus Mitterhauser

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, A-1090 Vienna, Austria
    • Hospital Pharmacy of the General Hospital of Vienna, A-1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Department of Nuclear Medicine, AKH Wien, Waehringer Guertel 18–20, A-1090 Vienna, Austria. Tel.: +43 1 40400 1557; fax: +43 1 40400 1559.

Received 13 August 2007; received in revised form 11 September 2007; accepted 27 September 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(07)00243-0

doi:10.1016/j.nucmedbio.2007.09.004

Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 61-66, January 2008